Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats M O’Shea, ME Singh, IS McGregor, PE Mallet Journal of psychopharmacology 18 (4), 502-508, 2004 | 357 | 2004 |
Adolescent rats find repeated Δ9-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure HR Quinn, I Matsumoto, PD Callaghan, LE Long, JC Arnold, ... Neuropsychopharmacology 33 (5), 1113-1126, 2008 | 343 | 2008 |
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist JE Gallate, T Saharov, PE Mallet, IS McGregor European journal of pharmacology 370 (3), 233-240, 1999 | 288 | 1999 |
Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats M O'Shea, IS McGregor, PE Mallet Journal of psychopharmacology 20 (5), 611-621, 2006 | 261 | 2006 |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by Δ9-tetrahydrocannabinol or anandamide PE Mallet, RJ Beninger Psychopharmacology 140, 11-19, 1998 | 237 | 1998 |
Increased anxiety and impaired memory in rats 3 months after administration of 3, 4-methylenedioxymethamphetamine (“ecstasy”) KC Morley, JE Gallate, GE Hunt, PE Mallet, IS McGregor European journal of pharmacology 433 (1), 91-99, 2001 | 162 | 2001 |
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake ANA Verty, JR McFarlane, IS McGregor, PE Mallet Endocrinology 145 (7), 3224-3231, 2004 | 136 | 2004 |
Δ9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance PE Mallet, RJ Beninger Life sciences 62 (26), 2431-2439, 1998 | 124 | 1998 |
Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats ANA Verty, IS McGregor, PE Mallet Neuroscience letters 354 (3), 217-220, 2004 | 119 | 2004 |
The endogenous cannabinoid receptor agonist anandamide impairs memory in rats PE Mallet, RJ Beninger Behavioural pharmacology 7 (3), 276-284, 1996 | 91 | 1996 |
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine ME Singh, ANA Verty, IS McGregor, PE Mallet Brain research 1026 (2), 244-253, 2004 | 90 | 2004 |
The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain JC Arnold, AN Topple, PE Mallet, GE Hunt, IS McGregor Brain research 921 (1-2), 240-255, 2001 | 88 | 2001 |
Paraventricular hypothalamic CB1 cannabinoid receptors are involved in the feeding stimulatory effects of Δ9-tetrahydrocannabinol ANA Verty, IS McGregor, PE Mallet Neuropharmacology 49 (8), 1101-1109, 2005 | 87 | 2005 |
Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor ‘silent antagonist’ A Gardner, PE Mallet European journal of pharmacology 530 (1-2), 103-106, 2006 | 80 | 2006 |
Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake ANA Verty, JR McFarlane, IS McGregor, PE Mallet Neuropharmacology 47 (4), 593-603, 2004 | 79 | 2004 |
Anxiety and aggression associated with the fermentation of carbohydrates in the hindgut of rats TL Hanstock, EH Clayton, KM Li, PE Mallet Physiology & behavior 82 (2-3), 357-368, 2004 | 78 | 2004 |
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats KC Morley, KM Li, GE Hunt, PE Mallet, IS McGregor Neuropharmacology 46 (7), 954-965, 2004 | 78 | 2004 |
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol ANA Verty, IS McGregor, PE Mallet Brain research 1020 (1-2), 188-195, 2004 | 74 | 2004 |
Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats CS Norwood, JL Cornish, PE Mallet, IS McGregor European journal of pharmacology 465 (1-2), 105-114, 2003 | 71 | 2003 |
A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part I: Development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology … LA Manwell, A Charchoglyan, D Brewer, BA Matthews, H Heipel, ... Journal of pharmacological and toxicological methods 70 (1), 120-127, 2014 | 67 | 2014 |